AwesomeCapital
Thursday, June 27, 2019
Vascular Biogenics started at Outperform by Oppenheimer
Target $2
https://www.benzinga.com/stock/VBLT/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.